Likewise, restraint stress rapidly modulated KP enzyme expression in rats, with amygdala IDO increasing within 1 h, amygdala KMO and kynureninase rising by 4 h, hippocampal TDO decreasing within 4 h, hypothalamic TDO upregulated at 4 h, and medial prefrontal cortex kynureninase reduced shortly after stress with effects lasting at least 24 h [70]
The dual-acting GLP-1/GIP Tirzepatide oral drop provides powerful support in a convenient, once-weekly, needle-free dose
doi: 10.1016/j.jpba.2016.12.037 117 LinghangQYiyiXGuoshengCKangXJiyuanTXiongLet al
Luckily, the math is pretty simple
While more research is needed in this area, a study looking at GLP1 receptor agonist use and opioid overdose risk in patients with type 2 diabetes and opioid use disorder (OUD) found that semaglutide was associated with reduced opioid overdose risk in patients with comorbid T2D and OUD